लोड हो रहा है...
Affordability and Price Increases of New Cancer Drugs in Clinical Guidelines, 2007–2016
In response to the rising cost of cancer drugs, the National Comprehensive Cancer Network (NCCN) recently developed a value framework, known as “Evidence Blocks,” to grade the efficacy, safety, evidence quality, evidence consistency, and affordability of treatments included in its clinical guideline...
में बचाया:
| में प्रकाशित: | JNCI Cancer Spectr |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Oxford University Press
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6649801/ https://ncbi.nlm.nih.gov/pubmed/31360849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pky016 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|